# DABIGATRAN

NDC: 50268-200
Generic name: DABIGATRAN ETEXILATE
Labeler / Manufacturer: AvPAK
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250712

FDA application: ANDA213879

## Active ingredients

- DABIGATRAN ETEXILATE MESYLATE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50268-200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50268-200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=39ac558a-b375-f3c1-e063-6394a90aa901